The indicators or indications are triggering clinically substantial distress or impairment in social, occupational, or other vital areas of functioning.       In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify cannabis as being a Agenda III drug. This rescheduling will figure out that cannabis has respecta